Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.35 is 117% above its 3-year average of 1.08, around the middle of its 3-year range (0.27–3.58).
As of the fiscal period ended Wednesday, December 31, 2025. 13.65% above its 12-month average of 2.07.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 2.35.
CURRENT RATIO
2.35
CURRENT RATIO AVG TTM
2.07
CURRENT RATIO AVG 3Y
1.08
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+13.65%
CURRENT VS 3Y AVG
+117.44%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.36
median of 505 covered companies
CURRENT VS SECTOR MEDIAN
-29.96%
vs the sector median at left
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Market Cap
$6.03M
Current Ratio
2.35
TTM Avg
2.07
3Y Avg
1.08
5Y Avg
N/A
Market Cap
$6.09M
Current Ratio
119.39
TTM Avg
100.04
3Y Avg
53.39
5Y Avg
40.10
Market Cap
$6.10M
Current Ratio
17.15
TTM Avg
11.86
3Y Avg
7.50
5Y Avg
9.06
Market Cap
$5.63M
Current Ratio
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$6.44M
Current Ratio
0.70
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.04
Market Cap
$5.54M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) | $6.03M | 2.35 | 2.07 | 1.08 | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 119.39 | 100.04 | 53.39 | 40.10 |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | 17.15 | 11.86 | 7.50 | 9.06 |
| Femasys Inc. (FEMY)vs › | $6.10M | 2.14 | 2.73 | 5.58 | 6.46 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 1.62 | 2.21 | 3.63 | 4.38 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | 0.70 | 2.00 | 1.31 | 1.04 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | 1.44 | 1.10 | 1.11 | 1.95 |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | 3.01 | 3.95 | 2.52 | 4.28 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 2.61 | 3.40 | 4.86 | 5.09 |
Current Ratio
2.35
Quick Ratio
2.35
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 2.35 |
| 2025-06-30 | 3.58 |
| 2024-12-31 | 0.27 |
| 2024-06-30 | 0.30 |
| 2023-12-31 | 0.32 |
| 2023-06-30 | 0.33 |
| 2022-12-31 | 0.41 |
